Teladoc Health, Inc. (NYSE:TDOC) Receives Average Recommendation of “Hold” from Analysts

Teladoc Health, Inc. (NYSE:TDOC) has been given a consensus recommendation of “Hold” by the eighteen brokerages that are currently covering the firm, MarketBeat reports. Eleven analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $10.94.

A number of brokerages have issued reports on TDOC. Needham & Company LLC reiterated a “hold” rating on shares of Teladoc Health in a report on Thursday, February 27th. The Goldman Sachs Group decreased their target price on Teladoc Health from $16.00 to $13.00 and set a “buy” rating on the stock in a research report on Monday, March 3rd. Oppenheimer cut their price target on Teladoc Health from $14.00 to $12.00 and set an “outperform” rating for the company in a report on Friday, January 24th. Bank of America decreased their price objective on Teladoc Health from $9.50 to $8.00 and set a “neutral” rating on the stock in a report on Friday. Finally, Piper Sandler cut their target price on shares of Teladoc Health from $13.00 to $12.00 and set an “overweight” rating for the company in a report on Thursday, February 27th.

Teladoc Health Stock Performance

NYSE:TDOC opened at $7.26 on Friday. The stock has a 50-day moving average price of $9.73 and a 200 day moving average price of $9.69. The stock has a market capitalization of $1.26 billion, a P/E ratio of -1.26 and a beta of 1.73. Teladoc Health has a 12-month low of $6.61 and a 12-month high of $15.21. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.07). Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The company had revenue of $640.49 million for the quarter, compared to analysts’ expectations of $639.44 million. Equities research analysts forecast that Teladoc Health will post -1.16 EPS for the current fiscal year.

Insider Buying and Selling

In related news, insider Adam C. Vandervoort sold 11,011 shares of the firm’s stock in a transaction dated Thursday, March 20th. The shares were sold at an average price of $8.42, for a total value of $92,712.62. Following the transaction, the insider now owns 64,308 shares of the company’s stock, valued at $541,473.36. This trade represents a 14.62 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.95% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Teladoc Health

Hedge funds have recently added to or reduced their stakes in the stock. Point72 Asset Management L.P. raised its stake in shares of Teladoc Health by 33.6% during the fourth quarter. Point72 Asset Management L.P. now owns 11,179,863 shares of the health services provider’s stock valued at $101,625,000 after acquiring an additional 2,813,568 shares in the last quarter. Maple Rock Capital Partners Inc. raised its position in Teladoc Health by 189.5% during the 4th quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider’s stock valued at $32,369,000 after purchasing an additional 2,331,000 shares in the last quarter. Two Sigma Investments LP purchased a new stake in shares of Teladoc Health in the 4th quarter worth $18,348,000. Two Sigma Advisers LP grew its position in shares of Teladoc Health by 213.0% during the 4th quarter. Two Sigma Advisers LP now owns 2,258,711 shares of the health services provider’s stock worth $20,532,000 after buying an additional 1,537,094 shares in the last quarter. Finally, Vanguard Group Inc. increased its stake in shares of Teladoc Health by 5.9% during the fourth quarter. Vanguard Group Inc. now owns 18,463,155 shares of the health services provider’s stock valued at $167,830,000 after buying an additional 1,029,829 shares during the period. 76.82% of the stock is currently owned by institutional investors.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.